6k enter trial to test recombinant BCG vaccine

Some 6,000 “high-risk” individuals, including frontline healthcare workers and close contacts of infected patients, will undergo tests to determine if a recombinant Bacille Calmette-Guerian (BCG) vaccine can boost human immunity against Covid-19.

from Pune News, Latest Pune News Headlines & Live Updates - Times of India https://timesofindia.indiatimes.com/city/pune/6000-enter-trial-to-test-recombinant-bcg-vaccine-against-covid-19/articleshow/75307117.cms

Comments

Popular posts from this blog

Pune collector to help migrants reach home

9th की स्टूडेंट ने 8वीं मंजिल से लगाई मौत की छलांग, लोग रोकने के लिए चिल्लाते रह गए